Cardiomyocyte specific deletion of Crif1 causes mitochondrial cardiomyopathy in mice

Area of Science:

• Mitochondrial biology
• Cardiovascular research
• Molecular genetics

Background:

• Mitochondria are crucial for cellular energy production.
• Crif1 protein interacts with mitochondrial ribosomes and is essential for respiratory protein synthesis and membrane insertion.
• The role of Crif1 in cardiac physiology remains largely unexplored.

Purpose of the Study:

• To investigate the physiological role of Crif1 in the adult mammalian heart.
• To determine the impact of cardiomyocyte-specific Crif1 deletion on cardiac function and mitochondrial integrity.

Main Methods:

• Generation of cardiac-specific Crif1 knockout mice using a tamoxifen-inducible Cre-lox system (Crif1(f/f) crossed with Myh6-cre/Esr1).
• Administration of tamoxifen at six weeks postnatal to induce gene deletion.
• Assessment of cardiac function, mitochondrial morphology, oxygen consumption, and ATP production in mutant mice.

Main Results:

• Mice with cardiomyocyte-specific Crif1 deletion developed severe hypertrophic heart failure and died within five months.
• Mutant cardiac muscles exhibited a dramatic increase in mitochondrial mass but lacked organized cristae.
• Significant reductions in oxygen consumption rates and ATP production were observed in Crif1-deficient cardiac muscles.

Conclusions:

• Crif1 is indispensable for maintaining mitochondrial structure and function in adult cardiac muscle.
• Disruption of Crif1 leads to mitochondrial dysfunction and subsequent heart failure.
• Targeting Crif1 may offer a therapeutic strategy for certain cardiac pathologies.